Credit Suisse’s BELLUS Health Inc. BLU Stock Holding History

Credit Suisse’s Portfolio BLU Stock Details BLU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-82,898	Closed	-$597K	–	3304
2023 Q1	$597K	Buy	82,898 +3,509	+4%	+$27.2K	﹤0.01%	2650
2022 Q4	$653K	Buy	79,389 +19,620	+33%	+$183K	﹤0.01%	2611
2022 Q3	$630K	Buy	59,769 +18,400	+44%	+$196K	﹤0.01%	2648
2022 Q2	$382K	Buy	+41,369	New	+$338K	﹤0.01%	3014
2020 Q4	–	Sell	-19,097	Closed	-$43K	–	4483
2020 Q3	$43K	Buy	19,097 +8	+0%	+$23	﹤0.01%	3964
2020 Q2	$196K	Buy	+19,089	New	+$193K	﹤0.01%	3745

Other funds holding BLU

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

VAM

Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

GLAM

Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return

Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

SAM

Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return

Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return

CUAMC

China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Credit Suisse's BLU Position: Q2 2023 in Review

Credit Suisse sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 82,898 shares — an estimated $597K sold.

Credit Suisse first reported a position in BLU in Q2 2020 and held it in 6 quarters. The position peaked at $653K in Q4 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

Credit Suisse reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
Credit Suisse sold 82,898 BELLUS Health Inc. shares in Q2 2023, an estimated $597K.
Credit Suisse first reported a position in BELLUS Health Inc. in Q2 2020 and held it in 6 quarters.
Credit Suisse's BELLUS Health Inc. position peaked at $653K in Q4 2022.
11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Credit Suisse's 13F filing for Q2 2023, filed 11 Aug 2023.